EUVIMEDEUVIMED entdecken
Crossref

Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients

Toshihisa Nakashima iD, Osamu Kobayashi, Mika Shiotsuka, Keiji Okinaka, Hironobu Hashimoto

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280261421670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Toshihisa Nakashima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Teicoplanin, Neoplasms, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Teicoplanin is widely used to treat Gram-positive infections in adult cancer patients, but early attainment of recommended trough concentrations and clinical determinants of those concentrations are not well characterized in patients receiving standardized, high-dose loading regimens.

Objective

This study aimed to characterize day 4 teicoplanin trough concentrations and to identify clinical predictors of under- and over-target levels in adult cancer patients receiving a standardized high-dose loading regimen.

Methods

This retrospective study included adult cancer patients who received a standardized high-dose teicoplanin loading regimen (600 mg intravenously twice daily on days 1-2 and once on day 3) and had a post-loading trough measurement on day 4. Patients were classified as under (< 20 mg/L), within (20-30 mg/L), or over target (> 30 mg/L). Clinical variables were compared across groups, and multivariable Firth-penalized logistic regression analysis was used to identify factors associated with under- and over-target trough concentrations vs within-target ones.

Results

The study included 211 patients: 71 (33.6%) in the under-, 112 (53.1%) in the within-, and 28 (13.3%) in the over-target group. Higher body weight and febrile neutropenia were associated with higher odds of under-target trough concentrations, whereas higher serum albumin was associated with lower odds; febrile neutropenia was associated with lower odds of over-target concentrations. Conclusion and Relevance: The fixed high-dose loading regimen of teicoplanin evaluated in this study achieves a day 4 trough concentration of 20 to 30 mg/L in about half of adult cancer patients. Higher body weight, febrile neutropenia, and lower serum albumin may help identify patients who require intensified loading and early therapeutic drug monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TeicoplaninNeoplasmsAnti-Bacterial AgentsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultDrug Monitoring

Stichwörter der Autor:innen

body weightcancer patientfebrile neutropeniaserum albuminteicoplanin

Substanzen

TeicoplaninAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Office of Infection Control and Prevention, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Toshihisa Nakashima

Zitieren

APA

Nakashima, T., Kobayashi, O., Shiotsuka, M., Okinaka, K., & Hashimoto, H. (2026). Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280261421670

Vancouver

Nakashima T, Kobayashi O, Shiotsuka M, Okinaka K, Hashimoto H. Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280261421670

BibTeX
@article{Nakashima2026,
  author = {Nakashima, Toshihisa and Kobayashi, Osamu and Shiotsuka, Mika and Okinaka, Keiji and Hashimoto, Hironobu},
  title = {Clinical Determinants of Early Achievement of the Therapeutic Teicoplanin Trough Concentration Range in Adult Cancer Patients},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280261421670}
}
Kostenlos starten →